Alkermes Announces 2021 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer

Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) announced the opening of applications for its Alkermes Inspiration Grants program on May 20, 2021. This initiative, now in its fifth year, offers up to $500,000 in grants to nonprofit organizations addressing the needs of individuals affected by addiction, serious mental illness, or cancer. The program prioritizes projects helping historically under-resourced communities. Applications will be accepted until June 17, 2021. Alkermes aims to support programs with a broad reach and sustained impact in healthcare.

Positive

• Alkermes will provide up to $500,000 in grants to support nonprofit organizations.
• The grants target historically under-resourced communities, enhancing Alkermes' community impact.

Negative

• None.

DUBLIN, May 13, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the company will begin accepting applications for its Alkermes Inspiration Grants^® program beginning on May 20, 2021. Now in its fifth year, this competitive grants program will provide up to a total of $500,000 in grants to assist nonprofit organizations in their work to address the needs of people living with addiction, serious mental illness or cancer. This program will prioritize funding for proposals that are designed to address the needs of historically under-resourced or underrepresented communities.

"Our grant programs serve an important purpose in helping drive positive changes in the healthcare system. These programs complement our central mission of developing innovative medicines designed to address unmet patient needs," said Richard Pops, Chief Executive Officer of Alkermes. "The Alkermes Inspiration Grants program seeks to support people living with highly-stigmatized diseases, who often face unique challenges due to longstanding and widespread health disparities. In its fifth year, this program will continue to fund innovative programs that seek to support the physical, social and emotional needs of people living with addiction, serious mental illness and cancer."

Alkermes is seeking to support programs with a broad reach across the U.S. that have the potential to lead to sustained impact. Submissions will be evaluated based on the set of criteria outlined in the request for proposals, including a focus on people living with mental illness, substance use disorders and/or cancer; clearly defined needs, objectives, activity format, mode of delivery and intended audience; and relevance to historically under-resourced or underrepresented communities. Grant recipients will be selected by Alkermes. Eligible U.S. 501(c)(3) nonprofit organizations may submit a grant application by visiting https://www.alkermes.com/responsibility. The 2021 application period will run from May 20, 2021 through June 17, 2021.

For more information on the Alkermes Inspiration Grants program, including the application, submission instructions and evaluation criteria, please visit https://www.alkermes.com/responsibility.

About Alkermes plc
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

ALKERMES INSPIRATION GRANTS is a registered service mark of Alkermes, Inc.

Alkermes Contacts:
For Investors: Alex Braun,    +1 781 296 9493
For Media:      Gretchen Murphy,  +1 781 609 6419

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/alkermes-announces-2021-alkermes-inspiration-grants-program-to-support-innovative-programs-focused-on-people-affected-by-addiction-serious-mental-illness-or-cancer-301290440.html

SOURCE Alkermes plc

FAQ

What are the Alkermes Inspiration Grants?

The Alkermes Inspiration Grants are competitive grants aimed at supporting nonprofit organizations that address the needs of individuals affected by addiction, serious mental illness, or cancer.

When can organizations apply for Alkermes Inspiration Grants in 2021?

Organizations can apply for the Alkermes Inspiration Grants from May 20, 2021, to June 17, 2021.

How much funding will be available through the Alkermes Inspiration Grants?

A total of up to $500,000 will be available through the Alkermes Inspiration Grants program.

Who can apply for the Alkermes Inspiration Grants?

Eligible U.S. 501(c)(3) nonprofit organizations can apply for the Alkermes Inspiration Grants.